Lipid Solubility and Drug Penetration of the Blood Brain Barrier
The DOI matches its Crossref record.
Abstract
Lipid/water partition coefficients of 19 radiolabeled drugs were correlated with uptake by brain during a single microcirculatory passage following carotid arterial injection. Uptake was measured relative to a simultaneously injected diffusible reference. When the lipid/ water partition coefficient was greater than about 0.03 a substantial fraction of the drug penetrated the blood-brain barrier and for most drugs above this range, uptake was essentially complete. These data suggest there is probably little reason to greatly exceed this degree of lipid solubility when designing drugs for blood-brain barrier penetration and central nervous system effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Still being checked.
Cited by
Items 101–200 of 378
Brain drug delivery technologies: novel approaches for transporting therapeutics
Temsamani, J., Scherrmann, J., Rees, A. R., & Kaczorek, M. (2000) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(00)00258-3 · Cited by 66
Singh, I. P., Swami, R., Jeengar, M. K., Khan, W., & Sistla, R. (2015) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2015.03.003 · Cited by 64
Takakura, Y., Audus, K. L., & Borchardt, R. T. (1991) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60034-4 · Cited by 63
Brain-Targeted Drug Delivery: Experiences to Date
Bodor, N. S., & Buchwald, P. (2003) · American Journal of Drug Delivery · doi:10.2165/00137696-200301010-00002 · Cited by 72
Yousuf, Z., Iman, K., Iftikhar, N., & Mirza, M. U. (2017) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s132074 · Cited by 69
In vivo labeling of amyloid with BF-108
Suemoto, T., Okamura, N., Shiomitsu, T., Suzuki, M., Shimadzu, H., Akatsu, H., Yamamoto, T., Kudo, Y., & Sawada, T. (2003) · Neuroscience Research · doi:10.1016/j.neures.2003.09.005 · Cited by 63
Shirasaka, T., Murakami, K., Ford, H., Kelley, J. A., YOSHIOKA, H., Kojima, E., Aoki, S., Broder, S., & Mitsuya, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9426 · Cited by 57
Bannwarth, B., Netter, P., Lapicque, F., Pr, P., Thomas, P., & Gaucher, A. (1990) · European Journal of Clinical Pharmacology · doi:10.1007/bf00315572 · Cited by 56
Sershen, H. W., Reith, M. E. A., Banay‐Schwartz, M., & Lajtha, Á. (1982) · Neurochemical Research · doi:10.1007/bf00965094 · Cited by 56
Gram-negative Bacillary Meningitis
LeFrock, J. L., Smith, B. R., & Molavi, A. (1985) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)31040-9 · Cited by 55
Lee, J., & Freeman, J. L. (2014) · Toxics · doi:10.3390/toxics2030464 · Cited by 60
Delivering Peptides to the Central Nervous System: Dilemmas and Strategies
Banks, W. A., Kastin, A. J., & Barrera, C. M. (1991) · Pharmaceutical Research · doi:10.1023/a:1015884603456 · Cited by 54
Westerhout, J., Smeets, J. M. W., Danhof, M., & de Lange, E. C. M. (2013) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-013-9314-4 · Cited by 53
Daniel, W. A., & Wójcikowski, J. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(99)00034-6 · Cited by 53
Mirza, M. U., & Ikram, N. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111748 · Cited by 53
Awasthi, M., Upadhyay, A., Singh, S., Pandey, V. P., & Dwivedi, U. N. (2017) · Molecular Simulation · doi:10.1080/08927022.2017.1334880 · Cited by 58
Green, M. A., Welch, M. J., Mathias, C. J., Fox, K. A. A., Knabb, R. M., & Huffman, J. C. (1985) · PubMed · Cited by 52
Kim, M., Laramy, J. K., Mohammad, A. S., Talele, S., Fisher, J. E., Sarkaria, J. N., & Elmquist, W. F. (2019) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.084210 · Cited by 53
Evidence for pore-like opening of the blood-brain barrier following forebrain ischemia in rats
Preston, E., & Foster, D. O. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00323-5 · Cited by 51
Measurement of filtration coefficient in single cerebral microvessels of the frog.
Fraser, P. A., Dallas, A. D., & Davies, S. (1990) · The Journal of Physiology · doi:10.1113/jphysiol.1990.sp018026 · Cited by 52
Rim, S., Audus, K. L., & Borchardt, R. T. (1986) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(86)90101-8 · Cited by 51
Lesniak, W. G., Chu, C., Jabłońska, A., Azad, B. B., Zwaenepoel, O., Zawadzki, M., Lisok, A., Pomper, M. G., Walczak, P., Gettemans, J., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04347-y · Cited by 49
Phenytoin: Basic and clinical pharmacology
Jones, G. L., Wimbish, G. H., & McIntosh, W. E. (1983) · Medicinal Research Reviews · doi:10.1002/med.2610030403 · Cited by 49
Nicholls, P. J. (1980) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/6.2.161 · Cited by 49
Assessment of Blood–Brain Barrier Permeability Using the In Situ Mouse Brain Perfusion Technique
Zhao, R., Kalvass, J. C., & Pollack, G. M. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9876-4 · Cited by 49
The molecular design of and challenges relating to sensitizers for cancer sonodynamic therapy
Zhou, Y., Wang, M., & Dai, Z. (2020) · Materials Chemistry Frontiers · doi:10.1039/d0qm00232a · Cited by 46
Bauer, T., Sipos, W., Stark, T. D., Käser, T., Knecht, C., Brunthaler, R., Saalmüller, A., Hofmann, T. F., & Ehling‐Schulz, M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02652 · Cited by 46
Genedani, S., Bernardi, M., & Bertolini, A. (1983) · Psychopharmacology · doi:10.1007/bf00427504 · Cited by 46
A physical-chemical model for cellular uptake of fatty acids: prediction of intracellular pool sizes
Cooper, R., Noy, N., & Zakim, D. (1987) · Biochemistry · doi:10.1021/bi00392a047 · Cited by 46
Scheffel, U., Goldfarb, H. W., Lever, S. Z., Rl, G., Burns, H. D., & Hn, W. (1988) · PubMed · Cited by 46
Silva, M. A. D. S., Topic, B., Huston, J. P., & Mattern, C. (2007) · Synapse · doi:10.1002/syn.20484 · Cited by 45
Mulac, D., Hüwel, S., Galla, H., & Humpf, H. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100431 · Cited by 45
Pharmacology of the Blood-Brain Barrier
Fenstermacher, J. D. (1989) · Springer eBooks · doi:10.1007/978-1-4613-0701-3_6 · Cited by 45
Rapid distribution of tryptophol (3-indole ethanol) to the brain and other tissues.
Cornford, E. M., Bocash, W. D., Braun, L. D., Crane, P. D., Oldendorf, W. H., & MacInnis, A. J. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109419 · Cited by 44
Self-citationAnimal models for studying transport across the blood-brain barrier
Bonate, P. L. (1995) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(94)00081-q · Cited by 52
Transport across the Blood-Brain Barrier
Bradbury, M. W. B. (1989) · Springer eBooks · doi:10.1007/978-1-4613-0701-3_5 · Cited by 46
Potential protection from toxicity by oral iron chelators
Hider, R. C. (1995) · Toxicology Letters · doi:10.1016/0378-4274(95)03606-7 · Cited by 41
Blut-Hirnschranke und Penetration von Zytostatika
Unger, C., Eibl, H., von Heyden, H. W., Krisch, B., & Nagel, G. A. (1985) · Journal of Molecular Medicine · doi:10.1007/bf01733202 · Cited by 41
Membrane Permeabilities of Ascorbic Acid and Ascorbate
Hannesschlaeger, C., & Pohl, P. (2018) · Biomolecules · doi:10.3390/biom8030073 · Cited by 41
The Blood‐Brain Barrier as a Tight Epithelium: Where Is Information Lacking?
Crone, C. (1986) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1986.tb27149.x · Cited by 39
van Bree, J. B. M. M., Baljet, A. V., van Geyt, A., Boer, A. G. D., Danhof, M., & Breimer, D. D. (1989) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01061457 · Cited by 37
Oral iron chelators – development and application
Liu, D. Y., Liu, Z. D., & Hider, R. C. (2002) · Best Practice & Research Clinical Haematology · doi:10.1016/s1521-6926(02)90209-4 · Cited by 45
Oral iron chelators: Prospects for future development
Porter, J. B. (1989) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1989.tb00300.x · Cited by 36
Bodor, N. S., & Brewster, M. E. (1991) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-75862-1_7 · Cited by 37
Ochs, H. R., Greenblatt, D. J., Abernethy, D. R., Arendt, R., Gerloff, J., Eichelkraut, W., & Hahn, N. (1985) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1985.tb03030.x · Cited by 36
Blood‐Brain Barrier Penetration of Felbamate
Cornford, E. M., Young, D., Paxton, J. W., & Sofia, R. D. (1992) · Epilepsia · doi:10.1111/j.1528-1157.1992.tb02205.x · Cited by 36
The CNS as a target for peptides and peptide-based drugs
Banks, W. A. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.6.707 · Cited by 35
Availability of liposome content to the nervous system. Liposomes and the blood-brain barrier
̈kés, Z. ́. A. T., ́teri, A. ́. K. ́. S. P., & Todd, J. A. (1980) · Brain Research · doi:10.1016/0006-8993(80)90578-8 · Cited by 35
Ikram, N., Mirza, M. U., Vanmeert, M., Froeyen, M., Salo‐Ahen, O. M. H., Tahir, M., Qazi, A. M., & Ahmad, S. (2019) · Biomolecules · doi:10.3390/biom9040124 · Cited by 36
Kumar, P., Sharma, G., Kumar, R., Malik, R., Singh, B., Katare, O. P., & Raza, K. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0082 · Cited by 35
Cerebral perfusion imaging tracers for SPECT: which one to choose?
Moretti, J., Çağlar, M., & Weinmann, P. (1995) · PubMed · Cited by 33
Reassessing the Role of Intra-Arterial Drug Delivery for Glioblastoma Multiforme Treatment
Ellis, J. A., Banu, M. A., Hossain, S. S., Singh‐Moon, R. P., Lavine, S. D., Bruce, J. N., & Joshi, S. (2015) · Journal of Drug Delivery · doi:10.1155/2015/405735 · Cited by 34
Advances in image-guided intratumoral drug delivery techniques
Solorio, L., Patel, R. B., Wu, H., Krupka, T. M., & Exner, A. (2010) · Therapeutic delivery · doi:10.4155/tde.10.20 · Cited by 34
Immunotoxin Therapy for CNS Tumor
Rustamzadeh, E., Low, W. C., Vallera, D. A., & Hall, W. A. (2003) · Journal of Neuro-Oncology · doi:10.1007/bf02700025 · Cited by 31
Fluorocarbon-23 measure of cat cerebral blood flow by nuclear magnetic resonance.
Ewing, J. R., Branch, C. A., Fagan, S. C., Helpern, J. A., Simkins, R., Butt, S., & Welch, K. M. A. (1990) · Stroke · doi:10.1161/01.str.21.1.100 · Cited by 30
Mirza, M. U., Ghori, N.-U.-H., Ikram, N., Adil, A. R., & Manzoor, S. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s75886 · Cited by 29
The influence of hydrogen bonding on partition coefficients
Borges, N. M., Kenny, P. W., Montanari, C. A., Prokopczyk, I. M., Ribeiro, J. F. R., da Rocha, J. R., & Sartori, G. (2017) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-016-0002-5 · Cited by 31
Péhourcq, F., Matoga, M., & Bannwarth, B. (2004) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2004.00201.x · Cited by 29
Heroin: Analgesia, toxicity and disposition in the mouse
Umans, J. G., & Inturrisi, C. E. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90218-7 · Cited by 29
Past, Present, and Future Drug Delivery Systems for Antiretrovirals
Kirtane, A. R., Langer, R., & Traverso, G. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.09.015 · Cited by 28
Prodrug strategy for enhanced therapy of central nervous system disease
Xia, X., Zhou, Y., & Gao, H. (2021) · Chemical Communications · doi:10.1039/d1cc02940a · Cited by 28
Entry of quinidine into cerebrospinal fluid
Ochs, H. R., Greenblatt, D. J., Lloyd, B. L., Woo, E., Sonntag, M., & Smith, T. W. (1980) · American Heart Journal · doi:10.1016/0002-8703(80)90148-9 · Cited by 28
Wang, H., Zhi, X., Qiu, J., Shi, L., & Lü, Z. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00337 · Cited by 28
Permeability of the Blood-Brain Barrier to a Rhenacarborane
Hawkins, P. M., Jelliss, P. A., Nonaka, N., Shi, X., & Banks, W. A. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.146878 · Cited by 28
Relative convulsant potencies of structural analogues of penicillin
Gutnick, M. J., van Duijn, H., & Citri, N. (1976) · Brain Research · doi:10.1016/0006-8993(76)91015-5 · Cited by 28
Begley, D. J. (1992) · Progress in brain research · doi:10.1016/s0079-6123(08)62331-6 · Cited by 28
Advances in the physicochemical profiling of opioid compounds of therapeutic interest
Mazák, K., Noszál, B., & Hosztafi, S. (2019) · ChemistryOpen · doi:10.1002/open.201900115 · Cited by 27
Opioids and pituitary function: expert opinion
Gadelha, M. R., Karavitaki, N., Fudin, J., Bettinger, J. J., Raff, H., & Ben-Shlomo, A. (2022) · Pituitary · doi:10.1007/s11102-021-01202-y · Cited by 27
Nasal administration of a physostigmine analogue (NXX-066) for Alzheimer's disease to rats
Dahlin, M., & Björk, E. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00612-8 · Cited by 27
Comparison of the blood-brain barrier and liver penetration of acridine antitumor drugs
Cornford, E. M., Young, D., & Paxton, J. W. (1992) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00684844 · Cited by 26
Active Transport of Nicotine by the Isolated Choroid Plexus In Vitro
Spector, R., & Goldberg, M. J. (1982) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1982.tb08669.x · Cited by 26
Anti-Hormonal Therapy in Breast Cancer and Its Effect on the Blood-Brain Barrier
Curtaz, C. J., Kiesel, L., Meybohm, P., Wöckel, A., & Burek, M. (2022) · Cancers · doi:10.3390/cancers14205132 · Cited by 27
Computational Prediction of CNS Drug Exposure Based on a Novel In Vivo Dataset
Bergström, C. A. S., Charman, S. A., & Nicolazzo, J. A. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0806-5 · Cited by 26
Sandoval, K. E., Farr, S. A., Banks, W. A., Niehoff, M. L., Morley, J. E., Crider, A. M., & WITT, K. A. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.12.013 · Cited by 26
Passage of Digoxin into Cerebrospinal Fluid in Man
Allonen, H. O., Andersson, K., Iisalo, E., Kanto, J., Strömblad, L. ‐., & Wettrell, G. (1977) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1977.tb02139.x · Cited by 25
Cleal, M., Gibbon, A. J., Fontana, B. D., & Parker, M. O. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.173066 · Cited by 24
Traditional neurotherapeutics approach intended for direct nose to brain delivery
Abolhassanzadeh, Z., Ashrafi, H., Badr, P., & Azadi, A. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.07.026 · Cited by 26
The design and properties of 3-hydroxypyridin-4-one iron chelators with high pFe3+ values
Hider, R. C., Liu, Z. D., & Piyamongkol, S. (2000) · Transfusion Science · doi:10.1016/s0955-3886(00)00090-4 · Cited by 24
Gora‐Harper, M. L. (1993) · Annals of Pharmacotherapy · doi:10.1177/106002809302700615 · Cited by 23
Regional blood‐brain barrier transport of the steroid hormones
Pardridge, W. M., & Metus, L. I. (1979) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1979.tb05192.x · Cited by 23
McEwen (2004) · doi:10.1016/s1054-3589(04)50016-9 · Cited by 22
Leppik, I. E., & Sherwin, A. L. (1979) · Epilepsia · doi:10.1111/j.1528-1157.1979.tb04796.x · Cited by 22
van Bree, J. B. M. M., de Boer, A. G., Danhof, M., & Breimer, D. D. (1993) · Pharmacy World & Science · doi:10.1007/bf02116163 · Cited by 24
The design and properties of 3-hydroxypyridin-4-one iron chelators with high pFe3+ values
Liu, Z. D., Piyamongkol, S., & Hider, R. C. (2000) · Transfusion Science · doi:10.1016/s0955-3886(00)00106-5 · Cited by 22
Vanbilloen, H. P., Cleynhens, B. J., & Verbruggen, A. (1998) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(98)00016-x · Cited by 22
Perekopskiy, D., & Kiyatkin, E. A. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00305 · Cited by 21
Correlation between lipid partition coefficients and surface permeation inSchistosoma japonicum
Cornford, E. M. (1982) · The Journal of Membrane Biology · doi:10.1007/bf01870888 · Cited by 21
Cerebral uptake of nicotine and of amino acids
Sershen, H. W., & Lajtha, Á. (1979) · Journal of Neuroscience Research · doi:10.1002/jnr.490040202 · Cited by 21
Antimicrobial Penetration into Cerebrospinal Fluid
Richards, M. L., Prince, R. A., Kenaley, K. A., Johnson, J. A., & LeFrock, J. L. (1981) · Annals of Pharmacotherapy · doi:10.1177/106002808101500505 · Cited by 21
Delivering Drugs Into the Brain: Barriers and Possibilities
Habgood, M. D., & Ek, C. J. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.58 · Cited by 20
Blood–brain barrier transport of naloxone does not involve P-glycoprotein-mediated efflux
Suzuki, T., Miyata, M., Zaima, C., Furuishi, T., Fukami, T., Kugawa, F., & Tomono, K. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21819 · Cited by 20
Neurochemical imaging of dementias
Minoshima, S., Frey, K. A., Cross, D. J., & Kuhl, D. E. (2004) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2003.09.008 · Cited by 20
Drug Disposition in the Mammalian Eye and Brain: A Comparison of Mechanisms
Leinweber, F.-J. (1991) · Drug Metabolism Reviews · doi:10.3109/03602539109029758 · Cited by 20
Exploring Low-Toxicity Chemical Space with Deep Learning for Molecular Generation
Yang, Y., Wu, Z., Yao, X., Kang, Y., Hou, T., Hsieh, C., & Liu, H. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00671 · Cited by 21
Jacus, M. O., Throm, S. L., Turner, D. C., Patel, Y. T., Freeman, B. B., Morfouace, M., Boulos, N., & Stewart, C. F. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.11.010 · Cited by 19
Khan, N., Bhat, R., Patel, A. K., & Ray, P. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1731602 · Cited by 19
Hider, R. C., Epemolu, O., Singh, S., & Porter, J. B. (1994) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-2554-7_36 · Cited by 19
Brain Uptake of lodine-131 Metaiodobenzylguanidine Following Therapy of Malignant Pheochromocytoma
Dwamena, B. A., Zempel, S., Klopper, J. F., van Heerden, B., WIELAND, D., & Shapiro, B. (1998) · Clinical Nuclear Medicine · doi:10.1097/00003072-199807000-00009 · Cited by 19
Traditional receptor theory and its application to neuroreceptor measurements in functional imaging
Kerwin, R. W., & Pilowsky, L. S. (1995) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf01254574 · Cited by 19
The effect of nicotine on the metabolism of brain proteins
Sershen, H. W., & Lajtha, Á. (1979) · Neuropharmacology · doi:10.1016/0028-3908(79)90019-4 · Cited by 19
Metadata
- Authors
- Oldendorf, W. H.
- Affiliations
- United States Department of Veterans Affairs (US)
- Corresponding author
- Oldendorf, W. H.
- Venue
- Experimental Biology and Medicine
- Publisher
- Frontiers Media SA
- Published
- 1974-12-01
- Volume
- 147
- Issue
- 3
- Pages
- 813-816
- ISSN
- 0071-3384 (ISSN-L)
- 1535-3702
- 1535-3699
- OpenAlex
- W1964863479
- Semantic Scholar
- 473c8dc715f4a5fb06cc8d3f2c9178786b369d64
- Cited by
- 373
- References
- 0
- Citations by year
- 2025: 2 · 2024: 6 · 2023: 3 · 2022: 6 · 2021: 5 · 2020: 6 · 2019: 10 · 2018: 8 · 2017: 12 · 2016: 9 · 2015: 11 · 2014: 4 · 2013: 5 · 2012: 6
- FWCI
- 4.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Experimental Biology and Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- blood-brain barrier, lipid solubility, lipid-water partition coefficient, drug penetration, brain uptake, radiolabeled drug
- MeSH terms
- Ethanol, Analgesics, Blood-Brain Barrier, Carbon Radioisotopes, Lipids, Phenytoin, Solubility, Tritium
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.